Taubenslag KJ, et al. - Researchers conducted this perspective study to illustrate strategies for and controversies surrounding the use of anti-inflammatory medications after uneventful cataract surgery, with a focus on the prevention of irreversible vision loss due to cystoid macular edema (CME). According to results, optimal pharmacologic treatment for inflammation following cataract surgery is still debatable. A consensus definition for clinically significant CME could aid in the comparison of anti-inflammatory drugs. To refine the treatment paradigm, well-designed trials examining both topical and extended-release drug-delivery systems are still needed.